Hu D - Search Results

1

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial.

Sun Y, Hu D, Stevens S, Lokhnygina Y, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Piccini JP, Singer DE, Fox KAA, Patel MR. Sun Y, et al. Among authors: hu d. Thromb Res. 2017 Aug;156:184-190. doi: 10.1016/j.thromres.2017.04.010. Epub 2017 Apr 13. Thromb Res. 2017. PMID: 28433206

2

[The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese].

Sun YH, Hu DY. Sun YH, et al. Zhonghua Nei Ke Za Zhi. 2004 Apr;43(4):258-60. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15130407 Clinical Trial. Chinese.

3

[Antithrombotic treatment in atrial fibrillation patients complicating coronary heart disease].

Sun YH, Hu DY. Sun YH, et al. Zhonghua Nei Ke Za Zhi. 2013 Jun;52(6):452. Zhonghua Nei Ke Za Zhi. 2013. PMID: 24059988 Chinese. No abstract available.

4

The link between diabetes and atrial fibrillation: cause or correlation?

Sun Y, Hu D. Sun Y, et al. Among authors: hu d. J Cardiovasc Dis Res. 2010 Jan;1(1):10-1. doi: 10.4103/0975-3583.59978. J Cardiovasc Dis Res. 2010. PMID: 21188083 Free PMC article. No abstract available.

5

Renal Dysfunction, CHADS₂ Score, and Adherence to the Anticoagulant Treatment in Nonvalvular Atrial Fibrillation.

Sun Y, Wang Y, Jiang J, Wang L, Hu D. Sun Y, et al. Among authors: hu d. Clin Appl Thromb Hemost. 2017 Apr;23(3):248-254. doi: 10.1177/1076029615611250. Epub 2016 Jul 9. Clin Appl Thromb Hemost. 2017. PMID: 26467322 Free article.

6

[The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].

Hu DY, Zhang HP, Sun YH, Jiang LQ; Antithrombotic Therapy in Atrial Fibrillation Study Group. Hu DY, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):295-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 16776915 Clinical Trial. Chinese.

7

Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: retrospective investigation of hospitalized patients.

Sun Y, Hu D, Li K, Zhou Z. Sun Y, et al. Among authors: hu d. Clin Cardiol. 2009 Feb;32(2):76-81. doi: 10.1002/clc.20232. Clin Cardiol. 2009. PMID: 19215006 Free PMC article.

8

Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis.

Liang R, Wang C, Zhao H, Huang J, Hu D, Sun Y. Liang R, et al. Among authors: hu d. Thromb Res. 2012 Jul;130(1):38-44. doi: 10.1016/j.thromres.2011.11.043. Epub 2011 Dec 20. Thromb Res. 2012. PMID: 22192158

9

Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.

Hu D, Sun Y. Hu D, et al. J Am Coll Cardiol. 2008 Sep 2;52(10):865-8. doi: 10.1016/j.jacc.2008.05.042. J Am Coll Cardiol. 2008. PMID: 18755352 Free article. No abstract available.

10

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).

Sun Y, Zhu J, Ma C, Liu S, Yang Y, Hu D. Sun Y, et al. Among authors: hu d. Cardiovasc Ther. 2019 Mar 21;2019:7372129. doi: 10.1155/2019/7372129. eCollection 2019. Cardiovasc Ther. 2019. PMID: 31772614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,367 results

Search Page

Filters